logo BDSP

Base documentaire


  1. Price regulation of pharmaceuticals in Canada.

    Article - En anglais

    Traduction en français : Régulation des prix des médicaments au Canada.

    Patent holding pharmaceutical firms are modeled as price-discriminating international monopolies.

    In an unregulated world market, firms set monopoly prices in each national market.

    Three types of regulatory rules : « reasonable » relationship rule, international price comparison rule, and « therapeutic » class comparison rule, are examined.

    While price regulation may lead to lower introductory prices for new drugs, the price of existing drugs may increase.

    Domestic price regulation may increase foreign prices.

    Canadian data supported the model's prediction.

    Policy makers should anticipate these responses that affects the entire vector of drug prices and not just those subject to specific regulations.

    Mots-clés Pascal : Régulation, Prix, Médicament, Concurrence économique, Modèle économétrique, Contrôle, Dépense, Economie santé, Canada

    Mots-clés Pascal anglais : Regulation(control), Price, Drug, Competition(economy), Econometric model, Check, Expenditure, Health economy, Canada

    Notice produite par :
    CREDES - Centre de Recherche, d'Etudes et de Documentation en Economie de la Santé (devenu IRDES)

    Cote : 15898, P79

    Code Inist : 002B30A11. Création : 11/09/1998.